|
1
|
Bosch FX, Ribes J and Borras J:
Epidemiology of primary liver cancer. Semin Liver Dis. 19:271–285.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taylor-Robinson SD, Foster GR, Arora S,
Hargreaves S and Thomas HC: Increase in primary liver cancer in the
UK, 1979–94. Lancet. 350:1142–1143. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB and Mason AC: Rising incidence
of hepatocellular carcinoma in the United States. N Engl J Med.
340:745–750. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malago M, Rogiers X and Broelsch CE: Liver
splitting and living donor techniques. Br Med Bull. 53:860–867.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ryder SD; British Society of
Gastroenterology, : Guidelines for the diagnosis and treatment of
hepatocellular carcinoma (HCC) in adults. Gut. 52 (Suppl
3):iii1–iii8. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johnson PJ: Hepatocellular carcinoma: Is
current therapy really altering outcome? Gut. 51:459–462. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bruix J and Llovet JM: Prognostic
prediction and treatment strategy in hepatocellular carcinoma.
Hepatology. 35:519–524. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bruix J, Sherman M, Llovet JM, Beaugrand
M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M
and Rodés J; EASL Panel of Experts on HCC, : Clinical management of
hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL
conference. European Association for the Study of the Liver. J
Hepatol. 35:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livraghi T: Guidelines for treatment of
liver cancer. Eur J Ultrasound. 13:167–176. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lai EC, Fan ST, Lo CM, Chu KM, Liu CL and
Wong J: Hepatic resection for hepatocellular carcinoma. An audit of
343 patients. Ann Surg. 221:291–298. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marin-Hargreaves G, Azoulay D and Bismuth
H: Hepatocellular carcinoma: Surgical indications and results. Crit
Rev Oncol Hematol. 47:13–27. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arii S, Yamaoka Y, Futagawa S, Inoue K,
Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K and Yamada
R: Results of surgical and nonsurgical treatment for small-sized
hepatocellular carcinomas: A retrospective and nationwide survey in
Japan. The Liver Cancer Study Group of Japan. Hepatology.
32:1224–1229. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fried MW: Treatment of hepatocellular
carcinoma: Medical options. Liver Transpl Surg. 4((5 Suppl 1)):
S92–S97. 1998.PubMed/NCBI
|
|
15
|
Ogihara M, Wong LL and Machi J:
Radiofrequency ablation versus surgical resection for single nodule
hepatocellular carcinoma: Long-term outcomes. HPB (Oxford).
7:214–221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ogata S, Belghiti J, Varma D, Sommacale D,
Maeda A, Dondero F and Sauvanet A: Two hundred liver hanging
maneuvers for major hepatectomy: A single-center experience. Ann
Surg. 245:31–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li L, Zhang J, Liu X, Li X, Jiao B and
Kang T: Clinical outcomes of radiofrequency ablation and surgical
resection for small hepatocellular carcinoma: A meta-analysis. J
Gastroenterol Hepatol. 27:51–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ng KKC, Chok KSH, Chan ACY, Cheung TT,
Wong TCL, Fung JYY, Yuen J, Poon RTP, Fan ST and Lo CM: Randomized
clinical trial of hepatic resection versus radiofrequency ablation
for early-stage hepatocellular carcinoma. Br J Surg. 104:1755–1784.
2017. View Article : Google Scholar
|
|
19
|
Machi J, Uchida S, Sumida K, Limm WM,
Hundahl SA, Oishi AJ, Furumoto NL and Oishi RH: Ultrasound-guided
radiofrequency thermal ablation of liver tumors: Percutaneous,
laparoscopic, and open surgical approaches. J Gastrointest Surg.
5:477–489. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poon RT, Fan ST, Tsang FH and Wong J:
Locoregional therapies for hepatocellular carcinoma: A critical
review from the surgeon's perspective. Ann Surg. 235:466–486. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH,
Zhang YQ, Lin XJ and Lau WY: A prospective randomized trial
comparing percutaneous local ablative therapy and partial
hepatectomy for small hepatocellular carcinoma. Ann Surg.
243:321–328. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang J, Yan L, Cheng Z, Wu H, Du L, Wang
J, Xu Y and Zeng Y: A randomized trial comparing radiofrequency
ablation and surgical resection for HCC conforming to the Milan
criteria. Ann Surg. 252:903–912. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng K, Yan J, Li X, Xia F, Ma K, Wang S,
Bie P and Dong J: A randomized controlled trial of radiofrequency
ablation and surgical resection in the treatment of small
hepatocellular carcinoma. J Hepatol. 57:794–802. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong SN, Lee SY, Choi MS, Lee JH, Koh KC,
Paik SW, Yoo BC, Rhee JC, Choi D, Lim HK, et al: Comparing the
outcomes of radiofrequency ablation and surgery in patients with a
single small hepatocellular carcinoma and well-preserved hepatic
function. J Clin Gastroenterol. 39:247–252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Montorsi M, Santambrogio R, Bianchi P,
Donadon M, Moroni E, Spinelli A and Costa M: Survival and
recurrences after hepatic resection or radiofrequency for
hepatocellular carcinoma in cirrhotic patients: A multivariate
analysis. J Gastrointest Surg. 9:62–67; discussion 67–68. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nishikawa H, Inuzuka T, Takeda H, Nakajima
J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S,
et al: Comparison of percutaneous radiofrequency thermal ablation
and surgical resection for small hepatocellular carcinoma. BMC
Gastroenterol. 11:1432011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vivarelli M, Guglielmi A, Ruzzenente A,
Cucchetti A, Bellusci R, Cordiano C and Cavallari A: Surgical
resection versus percutaneous radiofrequency ablation in the
treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg.
240:102–107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y and
Miao Y: Meta-analysis of surgical resection and radiofrequency
ablation for early hepatocellular carcinoma. World J Surg Oncol.
10:1632012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livraghi T, Meloni F, Di Stasi M, Rolle E,
Solbiati L, Tinelli C and Rossi S: Sustained complete response and
complications rates after radiofrequency ablation of very early
hepatocellular carcinoma in cirrhosis: Is resection still the
treatment of choice? Hepatology. 47:82–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tashiro H, Aikata H, Waki K, Amano H,
Oshita A, Kobayashi T, Tanimoto Y, Kuroda S, Tazawa H, Chayama K,
et al: Treatment strategy for early hepatocellular carcinomas:
Comparison of radiofrequency ablation with or without transcatheter
arterial chemoembolization and surgical resection. J Surg Oncol.
104:3–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Abu-Hilal M, Primrose JN, Casaril A,
McPhail MJ, Pearce NW and Nicoli N: Surgical resection versus
radiofrequency ablation in the treatment of small unifocal
hepatocellular carcinoma. J Gastrointest Surg. 12:1521–1526. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu JG, Wang YJ and Du Z: Radiofrequency
ablation in the treatment of small hepatocellular carcinoma: A meta
analysis. World J Gastroenterol. 16:3450–3456. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho YK, Rhim H and Noh S: Radiofrequency
ablation versus surgical resection as primary treatment of
hepatocellular carcinoma meeting the Milan criteria: A systematic
review. J Gastroenterol Hepatol. 26:1354–1360. 2011.PubMed/NCBI
|
|
34
|
Zhou Y, Zhao Y, Li B and Xu D:
Meta-analysis of radiofrequency ablation versus hepatic resection
for small hepatocellular carcinoma. BMC Gastroenterol. 10:782010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu XL, Liu XD, Liang M and Luo BM:
Radiofrequency ablation versus hepatic resection for small
hepatacellular carcinoma: Systematic review of randomized
controlled trials with meta-analysis and trial sequential analysis.
Radiology. 287:461–472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jadad AR, Moore RA, Carroll D, Jenkinson
C, Reynolds DJ, Gavaghan DJ and McQuay HJ: Assessing the quality of
reports of randomized clinical trials: Is blinding necessary?
Control Clin Trials. 17:1–12. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wells G, Shea B, O'Connell D, Peterson J,
Welch V, Losos M and Tugwell P: The Newcastle-Ottawa Scale (NOS)
for assessing the quality of nonrandomised studies in
meta-analyses. http://www.evidencebasedpublichealth.de/download/Newcastle_Ottowa_Scale_Pope_Bruce.pdf
|
|
38
|
Borenstein M, Hedges L, Higgins JPT and
Rothstein H: Fixed effect vs. random effectsIntroduction to
Meta-Analysis. John Wiley and Sons Ltd.; Chichester, UK: 2009,
View Article : Google Scholar
|
|
39
|
Yakoub D, Athanasiou T, Tekkis P and Hanna
GB: Laparoscopic assisted distal gastrectomy for early gastric
cancer: Is it an alternative to the open approach? Surg Oncol.
18:322–333. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang J, Hernandez-Alejandro R, Croome KP,
Yan L, Wu H, Chen Z, Prasoon P and Zeng Y: Radiofrequency ablation
versus surgical resection for hepatocellular carcinoma in Childs A
cirrhotics-a retrospective study of 1,061 cases. J Gastrointest
Surg. 15:311–320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo
RP, Shi M and Chen MS: Radiofrequency ablation versus hepatic
resection for the treatment of hepatocellular carcinomas 2 cm or
smaller: A retrospective comparative study. Radiology.
262:1022–1033. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sironi S, Livraghi T, Meloni F, De Cobelli
F, Ferrero C and Del Maschio A: Small hepatocellular carcinoma
treated with percutaneous RF ablation: MR imaging follow-up. AJR Am
J Roentgenol. 173:1225–1229. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Livraghi T, Goldberg SN, Lazzaroni S,
Meloni F, Ierace T, Solbiati L and Gazelle GS: Hepatocellular
carcinoma: Radio-frequency ablation of medium and large lesions.
Radiology. 214:761–768. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Livraghi T, Solbiati L, Meloni MF, Gazelle
GS, Halpern EF and Goldberg SN: Treatment of focal liver tumors
with percutaneous radio-frequency ablation: Complications
encountered in a multicenter study. Radiology. 226:441–451. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Goldberg SN and Gazelle GS: Radiofrequency
tissue ablation: Physical principles and techniques for increasing
coagulation necrosis. Hepatogastroenterology. 48:359–367.
2001.PubMed/NCBI
|
|
46
|
Miao Y, Ni Y, Yu J and Marchal G: A
comparative study on validation of a novel cooled-wet electrode for
radiofrequency liver ablation. Invest Radiol. 35:438–444. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Goldberg SN, Gazelle GS, Solbiati L,
Rittman WJ and Mueller PR: Radiofrequency tissue ablation:
Increased lesion diameter with a perfusion electrode. Acad Radiol.
3:636–644. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sasaki A, Kai S, Iwashita Y, Hirano S,
Ohta M and Kitano S: Microsatellite distribution and indication for
locoregional therapy in small hepatocellular carcinoma. Cancer.
103:299–306. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shiina S, Tagawa K, Unuma T, Takanashi R,
Yoshiura K, Komatsu Y, Hata Y, Niwa Y, Shiratori Y and Terano A:
Percutaneous ethanol injection therapy for hepatocellular
carcinoma. A histopathologic study. Cancer. 68:1524–1530. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mulier S, Ni Y, Jamart J, Ruers T, Marchal
G and Michel L: Local recurrence after hepatic radiofrequency
coagulation: Multivariate meta-analysis and review of contributing
factors. Ann Surg. 242:158–171. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Park EK, Kim HJ, Kim CY, Hur YH, Koh YS,
Kim JC, Kim HJ, Kim JW and Cho CK: A comparison surgical resection
and radiofrequency ablation in the treatment of hepatocellular
carcinoma. Ann Surg Treat Res. 87:72–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kutlu OC, Chan JA, Aloia TA, Chun YS,
Kaseb AO, Passot G, Yamashita S, Vauthey JN and Conrad C:
Comparative effectiveness of first-line radiofrequency ablation
versus surgical resection and transplantation for patents with
early hepatocellular carcinoma. Cancer. 123:1817–1827. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gravante G, Overton J, Sorge R, Bhardwaj
N, Metcalfe MS, Lloyd DM and Dennison AR: Radiofrequency ablation
versus resection for liver tumors: An evidence-based approach to
retrospective compartive studies. J Gastrointest Surg. 15:378–387.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Guo W, He X, Li Z and Li Y: Combination of
transarterial chemoembolization (TACE) and radiofrequency ablation
(RFA) vs. Surgical resection (SR) on survival outcome of early
hepatocellular carcinoma: A meta-analysis. Hepatogastroenterology.
62:710–714. 2015.PubMed/NCBI
|
|
55
|
Mathurin P, Raynard B, Dharancy S, Kirzin
S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC
and Naveau S: Meta-analysis: Evaluation of adjuvant therapy after
curative liver resection for hepatocellular carcinoma. Aliment
Pharmacol Ther. 17:1247–1261. 2003. View Article : Google Scholar : PubMed/NCBI
|
